Erratum to: Modulation of angiogenesis by genetic manipulation of ATF4 in mouse model of oxygen-induced retinopathy (Invest Ophthalmol Vis Sci., (2013), 54, (5995-6002), 10.1167/iovs.13-12117);Modulation of angiogenesis by genetic manipulation of atf4 in a mouse modulation of angiogenesis by genetic manipulation

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 9, 2013, Pages 5995-6002

  Wang, Xiaoqin ^a   Wang, Guibo ^a   Kunte, Mansi ^a   Shinde, Vishal ^b   Gorbatyuk, Marina ^b  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Activating transcription factor 4; Angiogenesis; Oxygen induced retinopathy; Unfolded protein response; Vascular endothelial growth factor

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR; ACTIVATING TRANSCRIPTION FACTOR 6; GLUCOSE REGULATED PROTEIN 78; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; GENETIC MANIPULATION; GENOTYPE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MICROSCOPY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETINOPATHY; WESTERN BLOTTING;

EID: 84884237696     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12117a     Document Type: Erratum

References (41)

1. Oshitari T, Fujimoto N, Hanawa K, Adachi-Usami E, Roy S. Effect of chronic hyperglycemia on intraocular pressure in patients with diabetes. Am J Ophthalmol. 2007;143:363-365.
2. Oshitari T, Polewski P, Chadda M, et al. Effect of combined antisense oligonucleotides against high-glucose- and diabetes-induced overexpression of extracellular matrix components and increased vascular permeability. Diabetes. 2006;55:86-92.
3. McAlpine CS, Bowes AJ, Werstuck GH. Diabetes, hyperglyce-mia and accelerated atherosclerosis: evidence supporting a role for endoplasmic reticulum (ER) stress signaling. Cardio-vasc Hematol Disord Drug Targets. 2010;10:151-157.
4. Oshitari T, Hata N, Yamamoto S. Endoplasmic reticulum stress and diabetic retinopathy. Vasc Health Risk Manag. 2008;4: 115-122.
5. Thuerauf DJ, Marcinko M, Gude N, et al. Activation of the unfolded protein response in infarcted mouse heart and hypoxic cultured cardiac myocytes. Circ Res. 2006;99:275-282.
6. Mujcic H, Rzymski T, Rouschop KM, et al. Hypoxic activation of the unfolded protein response (UPR) induces expression of the metastasis-associated gene LAMP3. Radiother Oncol. 2009; 92:450-459.
7. Ameri K, Harris AL. Activating transcription factor 4. Int J Biochem Cell Biol. 2008;40:14-21.
8. Roybal CN, Hunsaker LA, Barbash O, Vander Jagt DL, Abcouwer SF. The oxidative stressor arsenite activates vascular endothelial growth factor mRNA transcription by an ATF4-dependent mechanism. J Biol Chem. 2005;280:20331-20339.
9. Zhong Y, Li J, Chen Y, et al. Activation of endoplasmic reticulum stress by hyperglycemia is essential for Müller cell- derived inflammatory cytokine production in diabetes. Dia-betes. 2012;61:492-504.
10. Robinson R, Barathi VA, Chaurasia SS, Wong TY, Kern TS. Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals. Dis Model Mech. 2012;5:444-456.
11. Chen Y, Wang JJ, Li J, et al. Activating transcription factor 4 mediates hyperglycaemia-induced endothelial inflammation and retinal vascular leakage through activation of STAT3 in a mouse model of type 1 diabetes. Diabetologia. 2012;55:2533-2545.
12. Nakamura S, Imai S, Ogishima H, Tsuruma K, Shimazawa M, Hara H. Morphological and functional changes in the retina after chronic oxygen-induced retinopathy. PLoS One. 2012;7: e32167. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3279421/. Accessed August 9, 2013.
13. Li J, Wang JJ, Yu Q, Wang M, Zhang SX. Endoplasmic reticulum stress is implicated in retinal inflammation and diabetic retinopathy. FEBS Lett. 2009;583:1521-1527.
14. Connor KM, Krah NM, Dennison RJ, et al. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc. 2009;4:1565-1573.
15. Nakamura S, Takizawa H, Shimazawa M, et al. Mild endoplas-mic reticulum stress promotes retinal neovascularization via induction of BiP/GRP78. PLoS One. 2013;8:e60517. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3609792/. Accessed August 9, 2013.
16. Kunte MM, Choudhury S, Manheim JF, et al. ER stress is involved in T17M rhodopsin-induced retinal degeneration. Invest Ophthalmol Vis Sci. 2012;53:3792-3800.
17. Smith LE, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35: 101-111.
18. Choudhury S, Bhootada Y, Gorbatyuk O, Gorbatyuk M. Caspase-7 ablation modulates UPR, reprograms TRAF2-JNK apoptosis and protects T17M rhodopsin mice from severe retinal degeneration. Cell Death Dis. 2013;4:e528. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613823/. Accessed August 9, 2013.
19. Rapaport DH, Wong LL, Wood ED, Yasumura D, LaVail MM. Timing and topography of cell genesis in the rat retina. J Comp Neurol. 2004;474:304-324.
20. Firtina Z, Duncan MK. Unfolded protein response (UPR) is activated during normal lens development. Gene Expr Patterns. 2011;11:135-143.
21. Zhang X, Szabo E, Michalak M, Opas M. Endoplasmic reticulum stress during the embryonic development of the central nervous system in the mouse. Int J Dev Neurosci. 2007;25:455-463.
22. Blackshaw S, Harpavat S, Trimarchi J, et al. Genomic analysis of mouse retinal development. PLoS Biol. 2004;2:E247. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC439783/. Accessed August 15, 2013.
23. Vecino E, Hernandez M, Garcia M. Cell death in the developing vertebrate retina. Int J Dev Biol. 2004;48:965-974.
24. Yan S, Zheng C, Chen ZQ, et al. Expression of endoplasmic reticulum stress-related factors in the retinas of diabetic rats [published online ahead of print August 28, 2011]. Exp Diabetes Res. doi:10.1155/2012/743780.
25. Jacot JL, Sherris D. Potential therapeutic roles for inhibition of the PI3K/Akt/mTOR pathway in the pathophysiology of diabetic retinopathy [published online ahead of print October 30, 2011]. J Ophthalmol. doi:10.1155/2011/589813.
26. Ye X, Xu G, Chang Q, et al. ERK1/2 signaling pathways involved in VEGF release in diabetic rat retina. Invest Ophthalmol Vis Sci. 2010;51:5226-5233.
27. Mohammad G, Mairaj Siddiquei M, Imtiaz Nawaz M, Abu El-Asrar AM. The ERK1/2 inhibitor U0126 attenuates diabetes-induced upregulation of MMP-9 and biomarkers of inflamma-tion in the retina [published online ahead of print April 10, 2013]. J Diabetes Res. doi:10.1155/2013/658548.
28. Kador PF, Zhang P, Makita J, et al. Novel diabetic mouse models as tools for investigating diabetic retinopathy. PLoS One. 2012; 7:e49422. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520987/. Accessed August 9, 2013.
29. Lange PS, Chavez JC, Pinto JT, et al. ATF4 is an oxidative stress-inducible, prodeath transcription factor in neurons in vitro and in vivo. J Exp Med. 2008;205:1227-1242.
30. Chen Y, Wang JJ, Li J, et al. Activating transcription factor 4 mediates hyperglycaemia-induced endothelial inflammation and retinal vascular leakage through activation of STAT3 in a mouse model of type 1 diabetes. Diabetologia. 2012;55:2533-2545.
31. O'Driscoll C, Donovan M, Cotter TG. Analysis of apoptotic and survival mediators in the early post-natal and mature retina. Exp Eye Res. 2006;83:1482-1492.
32. Young RW. Cell death during differentiation of the retina in the mouse. J Comp Neurol. 1984;229:362-373.
33. Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L. IL-1b mediated up-regulation of HIF-1a via an NFjB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J. 2003;17:2115-2117.
34. Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 1996;16:4604-4613.
35. Arsham AM, Plas DR, Thompson CB, Simon MC. Akt and hypoxia-inducible factor-1 independently enhance tumor growth and angiogenesis. Cancer Res. 2004;64:3500-3507.
36. Zheng J, Wen Y, Song Y, et al. Activation of multiple signaling pathways is critical for fibroblast growth factor 2- and vascular endothelial growth factor-stimulated ovine fetoplacental endothelial cell proliferation. Biol Reprod. 2008;78:143-150.
37. Abid MR, Guo S, Minami T, et al. Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells. Arterioscler Thromb Vasc Biol. 2004;24:294-300.
38. Fujio Y, Walsh K. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J Biol Chem. 1999;274:16349-16354.
39. 1 production through a PI3K/Akt signalling pathway. Eur Respir J. 2008;31:523-531.
40. Hill JJ, Tremblay TL, Cantin C, O'Connor-McCourt M, Kelly JF, Lenferink AE. Glycoproteomic analysis of two mouse mam-mary cell lines during transforming growth factor (TGF)-b induced epithelial to mesenchymal transition. Proteome Sci. 2009;7:2. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2651118/. Accessed August 15, 2013.
41. Liu L, Qi X, Chen Z, et al. Targeting the IRE1a/XBP1 and ATF6 arms of the unfolded protein response enhances VEGF blockade to prevent retinal and choroidal neovascularization. Am J Pathol. 2013;182:1412-1424.